Low Molecular Weight Inhibitors Targeting the RNA-Binding Protein HuR
International Journal of Molecular Sciences, vol. 24, pp. 13127
Abstract
The RNA-binding protein human antigen R (HuR) regulates stability, translation, and nucleus-to-cytoplasm shuttling of its target mRNAs. This protein has been progressively recognized as a relevant therapeutic target for several pathologies, like cancer, neurodegeneration, as well as inflammation. Inhibitors of mRNA binding to HuR might thus be beneficial against a variety of diseases. Here, we present the rational identification of structurally novel HuR inhibitors. In particular, by combining chemoinformatic approaches, high-throughput virtual screening, and RNA-protein pulldown assays, we demonstrate that the 4-(2-(2,4,6-trioxotetrahydropyrimidin-5(2H)-ylidene)hydrazineyl)benzoate ligand exhibits a dose-dependent HuR inhibition effect in binding experiments. Importantly, the chemical scaffold is new with respect to the currently known HuR inhibitors, opening up a new avenue for the design of pharmaceutical agents targeting this important protein.
Authors 8
-
RWTH Aachen University · Forschungszentrum Jülich
Affiliation as printed
Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany
Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany
-
RWTH Aachen University · Forschungszentrum Jülich
Affiliation as printed
Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany
Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany
-
Affiliation as printed
Institute of Biology, University of Siegen, 57076 Siegen, Germany
-
Forschungszentrum Jülich · University of Verona
Affiliation as printed
Department of Biotechnology, University of Verona, 37134 Verona, Italy
Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany
-
Affiliation as printed
Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany
-
Sybille Krauß corresponding
Affiliation as printed
Institute of Biology, University of Siegen, 57076 Siegen, Germany
-
RWTH Aachen University · Forschungszentrum Jülich
Affiliation as printed
Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen University, 52062 Aachen, Germany
Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany
-
RWTH Aachen University · Forschungszentrum Jülich · Jülich Supercomputing Centre
Affiliation as printed
Department of Neurology, RWTH Aachen University, 44517 Aachen, Germany
Institute for Neuroscience and Medicine and Institute for Advanced Simulations (INM-9/IAS-5), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany
Jülich Supercomputing Centre (JSC), Forschungszentrum Jülich, 52425 Jülich, Germany
Cited by 10 stored of 10
10 results
No patents citing this paper on Lens.org (checked 2026-10-06).
References 75
-
W4367049415details pending0citations
-
W2946412700details pending0citations
-
W1980060880details pending0citations
-
W1984574291details pending0citations
-
W1984994707details pending0citations
-
W1988878711details pending0citations
-
W1997259050details pending0citations
-
W2014209078details pending0citations
-
W2017625394details pending0citations
-
W2019928317details pending0citations